Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure

about

Our Stance towards the 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline: Has the Pendulum Swung Too Far?

P2860

Q49317556-9C8F9055-FF76-4114-86E9-977A7397D808

P2860

Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure

Item

http://www.wikidata.org/entity/Q37448653

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Effect of Spironolactone on Pl ...... Chronic Systolic Heart Failure

@en

Effect of Spironolactone on Pl ...... hronic Systolic Heart Failure.

@nl

type

Item

label

Effect of Spironolactone on Pl ...... Chronic Systolic Heart Failure

@en

Effect of Spironolactone on Pl ...... hronic Systolic Heart Failure.

@nl

prefLabel

Effect of Spironolactone on Pl ...... Chronic Systolic Heart Failure

@en

Effect of Spironolactone on Pl ...... hronic Systolic Heart Failure.

@nl

P1476

Effect of Spironolactone on Pl ...... Chronic Systolic Heart Failure

@en

P2093

Atilla Bulut

http://www.w3.org/2001/XMLSchema#string

Ayşe Nur Topuz

http://www.w3.org/2001/XMLSchema#string

Mehmet Cosgun

http://www.w3.org/2001/XMLSchema#string

Murat Caylı

http://www.w3.org/2001/XMLSchema#string

Mustafa Topuz

http://www.w3.org/2001/XMLSchema#string

Omer Sen

http://www.w3.org/2001/XMLSchema#string

Oğuz Akkuş

http://www.w3.org/2001/XMLSchema#string

P2860

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility

Apelin, a newly identified adipokine up-regulated by insulin and obesity

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release

Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

Plasma apelin and ADMA Levels in patients with essential hypertension.

Mineralocorticoids, hypertension, and cardiac fibrosis.

P304

690-697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6515/ACS20160115A

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27899856

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

systole

P932

5126447

http://www.w3.org/2001/XMLSchema#string

Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure

about

P2860

P2860

Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932